Christine Bellon, Chief Legal Officer at Beam Therapeutics Inc. ($BEAM), sold shares on the open market seven times over the last year for a total of $839 thousand. Her latest sale occurred on January 22, 2026. These transactions rank her 5,327th among 11,678 insiders by sale value, well below the average of $8.6 million across 6.4 sales per insider. Bellon made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | Beam Therapeutics Inc. | $BEAM | Bellon Christine | Chief Legal Officer | A | Common Stock | 20000 | $0.00 | 115,667.0000 | 102,570,801 | 20.91% | 0.02% |
| Jan. 31, 2026 | Beam Therapeutics Inc. | $BEAM | Bellon Christine | Chief Legal Officer | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 102,570,801 | 9999.99% | 0.04% |
| Jan. 22, 2026 | Beam Therapeutics Inc. | $BEAM | Bellon Christine | Chief Legal Officer | S | Common Stock | 1371 | $34.00 | 95,667.0000 | 102,570,801 | 1.41% | 0.00% |
| Jan. 15, 2026 | Beam Therapeutics Inc. | $BEAM | Bellon Christine | Chief Legal Officer | S | Common Stock | 2111 | $33.62 | 113,556.0000 | 102,570,801 | 1.83% | 0.00% |
| Jan. 15, 2026 | Beam Therapeutics Inc. | $BEAM | Bellon Christine | Chief Legal Officer | S | Common Stock | 559 | $35.40 | 97,038.0000 | 102,570,801 | 0.57% | 0.00% |
| Jan. 15, 2026 | Beam Therapeutics Inc. | $BEAM | Bellon Christine | Chief Legal Officer | S | Common Stock | 15959 | $34.72 | 97,597.0000 | 102,570,801 | 14.05% | 0.02% |
| Dec. 31, 2025 | Beam Therapeutics Inc. | $BEAM | Bellon Christine | Chief Legal Officer | S | Common Stock | 1254 | $27.10 | 115,667.0000 | 102,570,801 | 1.07% | 0.00% |
| Oct. 1, 2025 | Beam Therapeutics Inc. | $BEAM | Bellon Christine | Chief Legal Officer | S | Common Stock | 373 | $24.53 | 116,921.0000 | 102,570,801 | 0.32% | 0.00% |
| April 1, 2025 | Beam Therapeutics Inc. | $BEAM | Bellon Christine | Chief Legal Officer | S | Common Stock | 5674 | $18.35 | 117,294.0000 | 82,313,008 | 4.61% | 0.01% |
| March 31, 2025 | Beam Therapeutics Inc. | $BEAM | Bellon Christine | Chief Legal Officer | A | Common Stock | 20000 | $0.00 | 122,968.0000 | 82,313,008 | 19.42% | 0.02% |
| Feb. 14, 2025 | Beam Therapeutics Inc. | $BEAM | Bellon Christine | Chief Legal Officer | M | Common Stock | 9492 | $7.22 | 112,460.0000 | 82,313,008 | 9.22% | 0.01% |
| Feb. 14, 2025 | Beam Therapeutics Inc. | $BEAM | Bellon Christine | Chief Legal Officer | M | Common Stock | 508 | $7.22 | 112,968.0000 | 82,313,008 | 0.45% | 0.00% |
| Feb. 14, 2025 | Beam Therapeutics Inc. | $BEAM | Bellon Christine | Chief Legal Officer | S | Common Stock | 10000 | $34.00 | 102,968.0000 | 82,313,008 | 8.85% | 0.01% |
| Feb. 14, 2025 | Beam Therapeutics Inc. | $BEAM | Bellon Christine | Chief Legal Officer | M | Stock Option (Right to Buy) | 508 | $0.00 | 10,410.0000 | 82,313,008 | 4.65% | 0.00% |
| Feb. 14, 2025 | Beam Therapeutics Inc. | $BEAM | Bellon Christine | Chief Legal Officer | M | Stock Option (Right to Buy) | 9492 | $0.00 | 0.0000 | 82,313,008 | 100.00% | 0.01% |
| Jan. 31, 2025 | Beam Therapeutics Inc. | $BEAM | Bellon Christine | Chief Legal Officer | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 82,313,008 | 9999.99% | 0.05% |
| Jan. 2, 2025 | Beam Therapeutics Inc. | $BEAM | Bellon Christine | Chief Legal Officer | S | Common Stock | 1241 | $24.68 | 102,968.0000 | 82,313,008 | 1.19% | 0.00% |
| Oct. 1, 2024 | Beam Therapeutics Inc. | $BEAM | Bellon Christine | Chief Legal Officer | S | Common Stock | 385 | $23.48 | 104,209.0000 | 82,410,095 | 0.37% | 0.00% |
| April 1, 2024 | Beam Therapeutics Inc. | $BEAM | Bellon Christine | Chief Legal Officer | S | Common Stock | 3401 | $32.12 | 104,594.0000 | 77,151,771 | 3.15% | 0.00% |
| March 31, 2024 | Beam Therapeutics Inc. | $BEAM | Bellon Christine | Chief Legal Officer | A | Common Stock | 27500 | $0.00 | 107,995.0000 | 77,151,771 | 34.16% | 0.04% |
| Jan. 31, 2024 | Beam Therapeutics Inc. | $BEAM | Bellon Christine | Chief Legal Officer | A | Stock Option (Right to Buy) | 55000 | $24.40 | 55,000.0000 | 77,151,771 | 9999.99% | 0.07% |
| Jan. 3, 2024 | Beam Therapeutics Inc. | $BEAM | Bellon Christine | Chief Legal Officer | S | Common Stock | 1907 | $26.42 | 80,495.0000 | 77,151,771 | 2.31% | 0.00% |
| Nov. 20, 2023 | Beam Therapeutics Inc. | $BEAM | Bellon Christine | Chief Legal Officer | S | Common Stock | 5000 | $31.00 | 82,402.0000 | 70,015,305 | 5.72% | 0.01% |
| Nov. 20, 2023 | Beam Therapeutics Inc. | $BEAM | Bellon Christine | Chief Legal Officer | M | Stock Option (Right to Buy) | 4182 | $0.00 | 9,492.0000 | 70,015,305 | 30.58% | 0.01% |
| Nov. 20, 2023 | Beam Therapeutics Inc. | $BEAM | Bellon Christine | Chief Legal Officer | M | Stock Option (Right to Buy) | 5818 | $0.00 | 10,918.0000 | 70,015,305 | 34.76% | 0.01% |
| Nov. 20, 2023 | Beam Therapeutics Inc. | $BEAM | Bellon Christine | Chief Legal Officer | S | Common Stock | 5000 | $30.00 | 87,402.0000 | 70,015,305 | 5.41% | 0.01% |
| Nov. 20, 2023 | Beam Therapeutics Inc. | $BEAM | Bellon Christine | Chief Legal Officer | M | Common Stock | 5818 | $7.22 | 92,402.0000 | 70,015,305 | 6.72% | 0.01% |
| Nov. 20, 2023 | Beam Therapeutics Inc. | $BEAM | Bellon Christine | Chief Legal Officer | M | Common Stock | 4182 | $7.22 | 86,584.0000 | 70,015,305 | 5.08% | 0.01% |
| Oct. 2, 2023 | Beam Therapeutics Inc. | $BEAM | Bellon Christine | Chief Legal Officer | S | Common Stock | 388 | $22.85 | 82,402.0000 | 70,015,305 | 0.47% | 0.00% |
| April 3, 2023 | Beam Therapeutics Inc. | $BEAM | Bellon Christine | Chief Legal Officer | S | Common Stock | 931 | $30.31 | 83,951.0000 | 70,015,305 | 1.10% | 0.00% |
| April 4, 2023 | Beam Therapeutics Inc. | $BEAM | Bellon Christine | Chief Legal Officer | S | Common Stock | 1161 | $29.09 | 82,790.0000 | 70,015,305 | 1.38% | 0.00% |
| March 31, 2023 | Beam Therapeutics Inc. | $BEAM | Bellon Christine | Chief Legal Officer | A | Common Stock | 17500 | $0.00 | 84,882.0000 | 70,015,305 | 25.97% | 0.02% |
| March 30, 2023 | Beam Therapeutics Inc. | $BEAM | Bellon Christine | Chief Legal Officer | M | Stock Option (Right to Buy) | 2669 | $0.00 | 16,736.0000 | 70,015,305 | 13.75% | 0.00% |
| March 30, 2023 | Beam Therapeutics Inc. | $BEAM | Bellon Christine | Chief Legal Officer | M | Stock Option (Right to Buy) | 6272 | $0.00 | 13,674.0000 | 70,015,305 | 31.44% | 0.01% |
| March 30, 2023 | Beam Therapeutics Inc. | $BEAM | Bellon Christine | Chief Legal Officer | M | Common Stock | 6272 | $7.22 | 64,713.0000 | 70,015,305 | 10.73% | 0.01% |
| March 30, 2023 | Beam Therapeutics Inc. | $BEAM | Bellon Christine | Chief Legal Officer | M | Common Stock | 2669 | $7.22 | 67,382.0000 | 70,015,305 | 4.12% | 0.00% |